GSK in China - where now?

► Subscribe to the Financial Times on YouTube: GlaxoSmithKline must pay the largest corporate fine ever levied in China after its subsidiary there was found guilty of bribery. Lex’s Oliver Ralph and Joseph Cotterill discuss what changes the pharmaceuticals group will have to make in the country. For more video content from the Financial Times, visit Subscribe to the Financial Times on YouTube; Twitter Facebook